Document is current

Any future updates will be listed below

Managing new premium-priced medicines in Europe

Crossref DOI link: https://doi.org/10.1186/2052-3211-8-S1-K2

Published: 2015-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

About CrossMark